Informações:
Falhas:
Palavras-chave
Anémie hypoplasique ×
- Clinical Trial (53)
- Disease Status (13)
- Laboratories (8)
- Treatment Form (7)
- Follow-Up Studies (6)
- Graft vs Host Disease (6)
- Disease Response (5)
- Adverse event (3)
- Baseline (2)
- Hematologic Tests (2)
- Infection (2)
- Radiotherapy (1)
- Registries (1)
- Registration (1)
- Specimen (1)
- Death (1)
- Medical History Taking (1)
- Pathology (1)
Índice
Modelos de dados selecionados
Deve ter sessão iniciada para selecionar vários modelos de dados e para os transferir ou analisar.
55 Resultados da pesquisa.
Grupos de itens: General Information, GENERAL INFORMATION, GENERAL INFORMATION, BONE MARROW FAILURE SYNDROME (INCLUDING APLASTIC ANAEMIA), SUBCLASSIFICATION, CYTOGENETICS, HAEMATOLOGICAL VALUES, COMPLICATIONS, PNH TESTS, FIRST IMMUNOSUPPRESSIVE TREATMENT EPISODE, IF 1ST TREATMENT EPISODE FOR THE PATIENT EVER, IF PATIENT HAS BEEN TREATED BEFORE, ADDITIONAL IMMUNOSUPPRESSIVE TREATMENT EPISODE, STATUS AT HSCT, ADDITIONAL TREATMENT POST-HSCT, BEST DISEASE RESPONSE AT 100 DAYS POST-HSCT, FORMS TO BE FILLED IN
Grupos de itens: FOLLOW UP Aplastic Anemia, OTHER COMPLICATIONS SINCE LAST REPORT, GRAFT VERSUS HOST DISEASE (GvHD) SINCE LAST REPORT, LAST DISEASE AND PATIENT STATUS, ADDITIONAL THERAPIES SINCE LAST FOLLOW UP, GRAFT ASSESSMENT AND HAEMOPOIETIC CHIMAERISM, ADDITIONAL NOTES IF APPLICABLE
Grupos de itens: Show identification of patient, Conditioning chemo therapy generic, Day of administration, Further administration (outside range of -1 to -15)
Grupos de itens: Show identification of patient, GvHD prophylaxis CSA, GvHD prophylaxis CSA application, GvHD prophylaxis MTX, GvHD prophylaxis MTX application, Other drug for GvHD prophylaxis, Other drug application for GvHD prophylaxis
Grupos de itens: Show identification of patient, General HSCT data
Grupos de itens: Show identification of patient, radiotherapy given, Conditioning radiotherapy admistration, Radionuclide therapy, Day of administration, Further administration (outside range of -1 to -15)
Grupos de itens: Show identification of patient, G-CSF immediate after HSCT, Other cytokine immediate after HSCT
Grupos de itens: Show identification of patient, Chemistry, HLA Type, Markers of infection, Fanconi anemia
Grupos de itens: Show identification of patient, GvHD occurred
Grupos de itens: Show identification of patient, Clinical features, Hepatitis, Respiratory symptoms, Bleeding site, Type of other symptoms, Organ dysfunction
Grupos de itens: Show identification of patient, Graft
Grupos de itens: Show identification of patient, IST FUP, Immunosuppressive Therapy - Steroids in given interval, Immunosuppressive Therapy - Cyclosporin A, Immunosuppressive Therapy - Cyclosporin A, Immunosuppressive Therapy - G-CSF, Complications - Infection, Complications - EBV PCR, Complications - EBV LPD, Complications - EBV LPD symptoms, Complications - EBV LPD site, Complications - EBV LPD treatment, Complications - Hemorrhage, Complications - Renal/Metabolic Lab., Creatinine, Complications - Other type of complication, Response - Transfusions, Response - Transfusion PLT, Response - Transfusion RBC, Response - Complete blood count, Response, Study centre specific variables